S. Nakajima

Serum immune modulators during the first cycle of anti‐PD‐1 antibody therapy in non‐small cell lung cancer: Perforin as a biomarker

M. Fukuoka, J. Uchino, K. Kudo, 2020, Thoracic cancer.